<div style=

摘要
图/表
参考文献(0)
相关文章 (6)

全文: PDF (1715 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要

目的：研究骨髓间充质干细胞（bone marrow mesenchymal stem cells，BMMSCs）输注对狼疮鼠血浆C3、IgG浓度及B细胞、浆细胞表面CXCR4表达的影响，分析BMMSCs改善系统性红斑狼疮疾病活动的机制。方法：分离培养C57BL/6小鼠的BMMSCs，并对MRL/lpr 狼疮鼠进行尾静脉输注。实验分为C57BL/6组（C57BL/6小鼠未进行尾静脉输注）、MRL/lpr组（MRL/lpr鼠未进行尾静脉输注）、BMMSCs组（MRL/lpr鼠12周龄注射BMMSCs）和PBS 组（MRL/lpr鼠12周龄注射PBS）。在20周末取小鼠的外周血、骨髓、脾脏进行流式细胞分析，检测B细胞、浆细胞表面CXCR4表达；同时取4组血浆，酶联免疫吸附试验（ELISA）检测C3、 IgG浓度。取小鼠肾脏组织行苏木精伊红（HE）染色。结果：① MRL/lpr组较C57BL/6组小鼠血浆C3浓度明显降低、IgG浓度明显增高（P均<0.01）；MRL/lpr组较C57BL/6组小鼠B细胞表面CXCR4的表达在外周血明显下降，在骨髓和脾脏明显升高（P均<0.01）；MRL/lpr组小鼠骨髓（P<0.05）及脾脏（P＜0.01）浆细胞表面CXCR4表达明显高于C57BL/6小鼠。② BMMSCs组较PBS组、MRL/lpr组C3浓度明显升高、IgG浓度明显降低（P均<0.01）； BMMSCs组较PBS组B细胞表面CXCR4表达在外周血明显增加（P<0.01），在骨髓（P<0.01）和脾脏（P<0.05）明显下降，较MRL/lpr组在骨髓和脾脏均明显下降（P均<0.01）。③ BMMSCs组较PBS组、MRL/lpr组浆细胞表面CXCR4表达在骨髓和脾脏均明显降低（P均<0.05）。④ 肾脏HE染色提示输注BMMSCs后狼疮鼠肾脏炎症改善。结论：BMMSCs输注可调节B细胞、浆细胞表面CXCR4的表达，改善MRL/lpr鼠病情活动指标。

	服务

	把本文推荐给朋友骨髓间充质干细胞输注对MRL/lpr狼疮鼠B淋巴细胞CXCR4表达的影响”的文章，特向您推荐。请打开下面的网址：http://zzs.ujs.edu.cn/xbyxb/CN/abstract/abstract2072.shtml" name="neirong">
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	马翠
	汤郁
	程孟微
	史伟
	郑文娟
	裘影影
	芮金兵
	王燕茹

关键词 ：系统性红斑狼疮, 骨髓间充质干细胞, CXC趋化因子受体4, B淋巴细胞

Abstract：Objective： To study the effects of bone marrow mesenchymal stem cells （BMMSCs） infusion on plasma C3 and IgG concentrations， and CXCR4 expression of B cells and plasma cells in MRL/lpr lupus mice， and to explore the mechanism of BMMSCs in regulating disease activity of systemic lupus erythematosus. Methods： BMMSCs were isolated from C57BL/6 mice and cultured， and then injected into MRL/lpr lupus mice by tail transfusion. All mice were divided into C57BL/6 group （C57BL/6 mice were not injected ）， MRL/lpr group （MRL/lpr mice were not injected with BMMSCs）， BMMSCs infusion group （MRL/lpr mice were injected with BMMSCs at 12 weeks）， and PBS control group （MRL/ lpr mice were injected with PBS at 12 weeks）.At the end of the 20th week， peripheral blood， bone marrow and spleen of mice were taken for flow cytometry analysis to detect CXCR4 expression in B and plasma cells， and then the plasma of the 4 groups were taken for ELISA to detect IgG and C3 level. The kidney of mice was stained with hematoxylineosin. Results： ① Compared with the C57BL/6 group， the plasma C3 level were decreased and IgG level were significantly increased in the MRL/lpr group（all P<0.01）. Compared with C57BL/6 group， the expression of CXCR4 on B cell surface in MRL/lpr group was significantly decreased in peripheral blood， and was significantly increased in bone marrow and spleen（all P<0.01）. The proportion of CXCR4 on plasma cell surface in bone marrow（P<0.05） and spleen（P<0.01） of MRL/lpr group was significantly higher than that of C57BL/6 mice.② Compared with PBS or MRL/lpr group， the level of C3 in BMMSCs group was significantly increased， while the level of IgG was significantly decreased（all P<0.01）. Compared with the PBS group， the expression of CXCR4 on B cell surface of BMMSCs group was significantly increased in peripheral blood（P<0.01）， and significantly decreased in bone marrow（P<0.01） and spleen（P<0.05）. Compared with the MRL/lpr group， the expression of CXCR4 on B cell surface of bone marrow and spleen was significantly decreased （all P<0.01）.③ Compared with PBS group or MRL/lpr group， the expression of CXCR4 on plasma cell surface in bone marrow and spleen of BMMSCs group was significantly decreased（all P<0.05）.④ Renal HE staining suggested attenuation of renal inflammation in MRL/lpr mice after infusion of BMMSCs. Conclusion： BMMSCs infusion can regulate the expression of CXCR4 on the surface of B and plasma cells and improve the disease activity index of MRL/lpr mice.

收稿日期: 2021-01-28

基金资助: 国家自然科学基金资助项目（81571582）；2017年高层次卫生人才“六个一工程”项目（LGY2017101）

通讯作者: 汤郁（通讯作者），主任医师，硕士生导师，E-mail： 1739833926@qq.com

作者简介: 马翠（1995—），女，硕士研究生

引用本文:

马翠，汤郁，程孟微，史伟，郑文娟，裘影影，芮金兵，王燕茹.

骨髓间充质干细胞输注对MRL/lpr狼疮鼠B淋巴细胞CXCR4表达的影响

[J]. 江苏大学学报:医学版, 2021, 31(05): 406-411. MA Cui， TANG Yu， CHENG Mengwei， SHI Wei， ZHENG Wenjuan，QIU Yingying， RUI Jinbing， WANG Yanru.

Effects of bone marrow mesenchymal stem cells infusion on CXCR4 expression in B cells of MRL/lpr lupus mice

. Journal of Jiangsu University(Medicine Edition), 2021, 31(05): 406-411.

链接本文:

http://zzs.ujs.edu.cn/xbyxb/CN/ 或 http://zzs.ujs.edu.cn/xbyxb/CN/Y2021/V31/I05/406

［1］Signorini V， Elefante E， Zucchi D， et al. One year in review 2020： systemic lupus erythematosus［J］. Clin Exp Rheumatol， 2020，38（4）：592-601.

［2］Ma K， Du W， Wang X， et al. Multiple functions of B cells in the pathogenesis of systemic lupus erythematosus［J］. Int J Mol Sci， 2019，20（23）：6021.

［3］Chong BF， Mohan C. Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus［J］. Expert Opin Ther Targets， 2009，13（10）：1147-1153.

［4］Hanaoka H， Okazaki Y， Hashiguchi A， et al. Overexpression of CXCR4 on circulating B cells in patients with active systemic lupus erythematosus［J］. Clin Exp Rheumatol， 2015，33（6）：863-870.

［5］Li H， Tian Y， Xie L， et al. Mesenchymal stem cells in allergic diseases： Current status［J］. Allergol Int， 2020，69（1）：35-45.

［6］Cheng RJ， Xiong AJ， Li YH， et al. Mesenchymal stem cells： allogeneic MSC may be immunosuppressive but autologous MSC are dysfunctional in lupus patients［J］.Front Cell Dev Biol， 2019，7：285.

［7］Wang M， Yuan Q， Xie L. Mesenchymal stem cellbased immunomodulation： properties and clinical application［J］.Stem Cells Int， 2018，2018：1-12.

［8］Yuan L， Xiao ZT， Huang XZ， et al. Human embryonic mesenchymal stem cells alleviate pathologic changes of MRL/Lpr mice by regulating Th7 cell differentiation［J］. Ren Fail， 2016，38（9）：1432-1440.

［9］白静.免疫球蛋白与补体C3、C4联合检测对系统性红斑狼疮的诊断价值［J］.医疗装备， 2020，33（4）：32-33.

［10］Flynn RJ. CD95 and the MRLlpr mouse model［J］. Methods Mol Biol， 2017，1557：219-228.

［11］Thong B， Olsen NJ. Systemic lupus erythematosus diagnosis and management［J］. Rheumatology（Oxford）， 2017， 56（suppl_1）：i3-i13.

［12］束庆，范晴晴，刘蕴星，等.间充质干细胞移植在治疗自身免疫性疾病中的应用进展［J］.药学进展， 2019，43（4）：276-281.

［13］Ji J， Wu Y， Meng Y， et al. JAKSTAT signaling mediates the senescence of bone marrowmesenchymal stem cells from systemic lupus erythematosus patients［J］. Acta Biochim Biophys Sin （Shanghai）， 2017，49（3）：1-8.

［14］de la Varga Martínez R，RodríguezBayona B，Aez GA， et al. Clinical relevance of circulating antiENA and antidsDNA secreting cells from SLE patients and their dependence on STAT3 activation［J］. Eur J Immunol， 2017，47（7）：1211-1219.

［15］Malkiel S， Barlev AN， AtishaFregoso Y， et al. Plasma cell differentiation pathways in systemic lupus erythematosus［J］.Front Immunol， 2018，9：427-448.

［16］Ma K， Li J， Wang X， et al.TLR4+CXCR4+ plasma cells drive nephritis development in systemic lupus erythematosus［J］.Ann Rheum Dis， 2018，77（10）：1498-1506.

［17］Adriano T， Laleh K， Caroline V， et al. Longlived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors［J］.Arthritis Res Ther， 2015，17（1）：1-12.

［18］Ellyard JI， Avery DT， Mackay CR， et al. Contribution of stromal cells to the migration， function and retention of plasma cells in human spleen： potential roles of CXCL12， IL6 and CD54［J］.Eur J Immunol， 2005，35（3）：699-708.

［19］Wang W， RangelMoreno J， Owen T， et al. Longterm B cell depletion in murine lupus eliminates autoantibodysecreting cells and is associated with alterations in the kidney plasma cell niche［J］.J Immunol， 2014，192（7）：3011-3020.